Let's connect

Want to discuss your project or have any questions?

2Go platform

Accelerate your research with Assays2Go and Xrays2Go

Drawing on our extensive experience in commercial drug discovery, we offer a robust and growing catalogue of proprietary Assays2Go and Xrays2Go systems for therapeutically interesting targets. For these targets, we have developed robust experimental platforms to deliver both activity characterisation and high-quality complex structures for your ligands of interest. 

Assays2Go and Xrays2Go systems for therapeutically interesting targets

Xrays2Go 

Nuvisan’s Xrays2Go Service includes a growing portfolio of proprietary crystal systems for therapeutically highly interesting targets. We have established robust gene-2-structure protocols to deliver high-quality complex structures for your ligands of interest. To increase your confidence in ligand selection before embarking on structure-determination activities, we offer additional up-front biophysical verification of ligand binding to the X-ray protein. Complex structures are delivered with rapid turnaround times to support your compound characterisation and optimisation activities.

Assays2Go 

Our validated miniaturised assay protocols deliver robust, high-quality data for compound profiling, mode-of-action analysis and high-throughput screening (HTS) in 384- and 1536-well formats. Rapid turnaround times and data reporting tailored to your needs can accelerate your project. 

Nuvisan’s Assays2Go service has a growing catalogue for:
  • Profiling of your compounds
  • High-throughput screening (Nuvisan or your library)
  • Therapeutically highly interesting targets
  • Robust, reproducible and sensitive assay protocols
  • High-quality data for your compounds of interest
  • Rapid turnaround times
  • Data reporting tailored to your needs.
 



Protein Name UniProt ID Xrays2GO Assays2Go
AKR1C3 P42330 Y
AMPK2 P54646 Y
ATAD2 Q6PL18 Y Y
BCAT1 P54687 Y
BRD4 (BD1) O60885 Y
BRPF1 P55201 Y Y
BRPF2 O95696 Y Y
BUB1 O43683 Y Y
Calpain-1 P97571 Y
CDK12/Cyclin-K Q9NYV4/O75909 Y
CDK2 P24941 Y
Cereblon-TBD Q96SW2 Y
CHK-1 O14757 Y
ChukA P35790 Y Y
Chymase P23946 Y
DHODH O02127 Y
EHMT1 Q9H9B1 Y Y
Elastase P08246 Y
Factor XIa P03951 Y
GLS1 O94925 Y
GPX4 P36969 Y
HIF2a O99814 Y Y
HIF2a/ARNT Q99814/P27540 Y
HIF-PH Q9GZT9 Y
IRAK4 Q9NWZ3 Y Y
JARID1B Q9UGL1 Y
LDH-A P00338 Y
MAGL Q99685 Y
MetAP2 P50579 Y
MMP12 P39900 Y
MPS1 P33981 Y Y
MST1 Q13043 Y
MTH1 P36639 Y Y
MTHFD2 P13995 Y
NAMPT P43490 Y Y
NEK2 P51955 Y Y
p53 (Y220C) P04637 Y
PGAM P18669
PHGDH O43175 Y
PIM1 P11309 Y Y
PI4K2A P48426 Y
PLK1 P53350 Y Y
PPARδ P37231 Y
PREP P23687 Y
PRMT5-MEP50 O14744 Y
PRMT6 Q96LA8 Y
PXR O75469 Y
PYCR1 P32322 Y
SMYD2 Q9NRG4 Y Y
SMYD3 Q9H784 Y
SRPK1 Q96584 Y Y
Tankyrase2 Q9H2K2 Y
TAOK1 Q7L7X3 Y
TEAD2 Q15562 Y
Thrombin P00734 Y
tPA (catalytic) P00750
tPA (Kringle) P00750 Y
uPA P00749 Y
ZPI Q9UK55 Y
KAT6A Q92794 Y Y
STING Q86WV6 Y
Murf1 Q969Q1 Y
MAP4K1 Q92918 Y Y
ACBP P07108 Y
KLHL7 Q8IXQ5 Y
BRD4 BD2 O60885 Y
KAT6B Q8WYB5 Y
KAT5 Q92993 Y
KAT7 O95251 Y
KAT8 Q9H7Z6 Y
PIM2 Q9P1W9 Y
PIM3 Q86V86 Y

Related topics & resources

Discussing new lead optimization strategies identified from a new target-compound structure.

X-ray crystallography

Our X-ray crystallography services offer detailed insights into molecular structures, aiding in drug design and development. 

learn more
Young scientists explains an automated screening system to another person.

Biochemical assays

Explore how tailored biochemical assays can support your hit identification and validation process. 

learn more
three lab technicians working at the clean bench.

Cell-based assays

Discover our large portfolio of cell-based assays.

learn more